Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage

Nucleic Acids Research

Volumn 37, Issue 1, 2009, Pages 78-95

  Wilson, Peter M ^a   Fazzone, William ^a   Labonte, Melissa J ^a   Lenz, Heinz Josef ^a   Ladner, Robert D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; FLUOROPYRIMIDINE; FLUOROURACIL; MESSENGER RNA; MUTANT PROTEIN; OXALIPLATIN; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SP1; URACIL;

ARTICLE; CELL STRAIN HCT116; CONTROLLED STUDY; DNA DAMAGE; DNA METABOLISM; DNA SYNTHESIS; DOWN REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; NULL CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; CELL LINE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEOXYURACIL NUCLEOTIDES; DNA DAMAGE; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ORGANOPLATINUM COMPOUNDS; PROMOTER REGIONS, GENETIC; PYROPHOSPHATASES; REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58549097306     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn910     Document Type: Article

References (63)

1. el-Hajj,H.H., Zhang,H. and Weiss,B. (1988) Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J. Bacteriol., 170, 1069-1075.
2. Gadsden,M.H., McIntosh,E.M., Game,J.C., Wilson,P.J. and Haynes,R.H. (1993) dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae. EMBO J., 12, 4425-4431.
3. Longley,D.B., Harkin,D.P. and Johnston,P.G. (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev Cancer, 3, 330-338.
4. Curtin,N.J, Harris,A.L. and Aherne,G.W. (1991) Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res. 51, 2346-2352.
5. Webley,S.D., Welsh,S.J., Jackman,A.L. and Aherne,G.W. (2001) The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. Br. J. Cancer, 85, 446-452.
6. Tinkelenberg,B.A., Hansbury,M.J. and Ladner,R.D. (2002) dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae. Cancer Res., 62, 4909-4915.
7. Studebaker,A.W., Lafuse,W.P., Kloesel,R. and Williams,M.V. (2005) Modulation of human dUTPase using small interfering RNA. Biochem. Biophys. Res. Commun., 327, 306-310.
8. Canman,C.E., Radany,E.H., Parsels,L.A., Davis,M.A., Lawrence,T.S. and Maybaum,J. (1994) Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridinetriphosphatase. Cancer Res., 54 2296-2298.
9. Kochler,S.E. and Ladner,R.D. (2004) Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. Mol. Pharmacol., 66, 620-626.
10. Ladner,R.D., Lynch,F.J., Groshen,S., Xiong,Y.P., Sherrod,A., Caradonna,S.J., Stochlmacher,J. and Lenz,H.J. (2000) dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Cancer Res., 60, 3493-3503.
11. Wilson,P.M., Fazzone,W., LaBonte,M.J., Deng,J., Neamati,N. and Ladner,R.D. (2008) Novel opportunities for thymidylate metabolism as a therapeutic target. Mol. Cancer Ther., 7, 3029-3037.
12. Mol,C.D., Harris,J.M., McIntosh,E.M. and Tainer,J.A. (1996) Human dUTP pyrophosphatase: Uracil recognition by a beta hairpin and active sites formed by three separate subunits. Structure, 4, 1077-1092.
13. Toth,J., Varga,B., Kovacs,M., Malnasi-Csizmadia,A. and Vertessy,B.G. (2007) Kinetic mechanism of human dUTPase, an essential nucleotide pyrophosphatase enzyme. J. Biol. Chem., 282, 33572-33582.
14. Varga,B. Barabas,O., Kovari,J., Toth,J., Hunyadi-Gulyas,E., Klement,E., Medzihradszky,K.F., Tolgyesi,F., Fidy,J. and Vertessy,B.G. (2007) Active site closure facilitates juxtaposition of reactant atoms for initiation of catalysis by human dUTPase. FEBS Lett., 581, 4783-4788.
15. Ladner,R.D. and Caradonna,S.J. (1997) The human dUTPase gene encodes both nuclear and mitochondrial isoforms. Differential expression of the isoforms and characterization of a cDNA encoding the mitochondrial species. J. Biol. Chem., 272, 19072-19080.
16. Webley,S.D., Hardcastle,A., Ladner,R.D., Jackman,A.L. and Aherne,G.W. (2000) Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331. Br. J. Cancer, 83, 792-799.
17. Fleischmann,J., Kremmer,E., Muller,S., Sommer,P., Kirchner,T., Niedobitek,G. and Grasser,F.A. (1999) Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int. J. Cancer, 84, 614-617.
18. Ren,B., Cam,H., Takahashi,Y., Volkert,T., Terragni,J., Young,R.A. and Dynlacht,B.D. (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev., 16, 245-256.
19. Kajimoto,S., Horic,M., Manabe,H., Masuda,Y., Shibayama-Imazu,T., Nakajo,S., Gong,X.F., Obama.T., Itabe,H. and Nakaya,K. (2007) A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity. Biochim. Biophys. Acta., 1782, 41-50.
20. Lee,S.C., Chan,J., Clement,M.V. and Pervaiz,S. (2006) Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop. Proteomics, 6, 2386-2394.
21. Hernandez-Vargas,H., Ballestar,E., Carmona-Saez,P., von Kobbe,C., Banon-Rodriguez,I., Esteller,M., Moreno-Bueno,G. and Palacios,J. (2006) Transcriptional profiting of MCF7 breast cancer cells in response to 5-fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int. J. Cancer, 119, 1164-1175.
22. Spurgers,K.B., Gold,D.L., Coombes,K.R., Bohnenstiehl,N.L., Mullins,B., Meyn,R.E., Logothetis,C.J. and McDonnell,T.J. (2006) Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J. Biol. Chem., 281, 25134-25142.
23. Voskuil,D.W., Kampman,E., van Kraats,A.A., Balder,H.F., van Muijen,G.N., Goldbohm,R.A. and van't Veer,P. (1999) p53 over-expression and p53 mutations in colon carcinomas: Relation to dietary risk factors. Int. J. Cancer, 81, 675-681.
24. Pugacheva,E.N., Ivanov,A.V., Kravchenko, J.E., Kopnin, B.P., Levine,A.J. and Chumakov,P.M. (2002) Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil. Oncogene, 21, 4595-4600.
25. Tinkelenberg,B.A., Fazzone,W., Lynch,F.J. and Ladner,R.D. (2003) Identification of sequence determinants of human nuclear dUTPase isoform localization. Exp. Cell Res., 287, 39-46.
26. Ladner,R.D., McNulty,D.E., Carr,S.A., Roberts,G.D. and Caradonna,S.J. (1996a) Characterization of distinct nuclear and mitochondrial forms of human deoxyuridine triphosphate nucleotidohydrolase. J. Biol. Chem. 271, 7745-7751.
27. Sherman,P.A. and Fyfe,J.A. (1989) Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem., 180, 222-226.
28. Horowitz,R.W., Zhang,H., Schwartz,E.L., Ladner,R.D. and Wadler,S. (1997) Measurement of deoxyuridine triphosphate and thymidine triphosphate in the extracts of thymidylate synthase-inhibited cells using a modified DNA polymerase assay. Biochem. Pharmacol., 54, 635-638.
29. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
30. Mandola,M.V., Stoehlmacher,J., Muller-Weeks,S., Cesarone,G., Yu,M.C., Lenz,H.J. and Ladner,R.D. (2003) A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res., 63, 2898-2904.
31. Jensen,D.E., Black,A.R., Swick,A.G. and Azizkhan,J.C. (1997) Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J. Cell. Biochem., 67, 24-31.
32. Lin,S.Y., Black,A.R., Kostic,D., Pajovic,S., Hoover,C.N. and Azizkhan,J.C. (1996) Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol., 16 1668-1675.
33. Safe,S. and Abdelrahim,M. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer, 41, 2438-2448.
34. Koutsodontis,G. and Kardassis,D. (2004) Inhibition of p53-mediated transcriptional responses by mithramycin A. Oncogene, 23, 9190-9200.
35. Lakin,N.D. and Jackson,S.P. (1999) Regulation of p53 in response to DNA damage. Oncogene, 18, 7644-7655.
36. Longley,D.B., Allen,W.L. and Johnston,P.G. (2006) Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim. Biophys. Acta, 1766, 184-196.
37. Rothenberg,M.L., Oza,A.M., Bigelow,R.H., Berlin,J.D., Marshall,J.L., Ramanathan,R.K., Hart,L.L., Gupta,S., Garay,C.A., Burger,B.G. et al. (2003) Superiority of oxaliplatin and fluorouracil- leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III. trial. J. Clin. Oncol., 21, 2059-2069.
38. Fischer,J.A., Muller-Weeks,S. and Caradonna,S. (2004) Proteolytic degradation of the nuclear isoform of uracil-DNA-glycosylase occurs during the S phase of the cell cycle. DNA Repair, 3, 505-513.
39. Fischer,J.A., Muller-Weeks,S. and Caradonna,S.J. (2006) Fluorodeoxyuridine Modulates Cellular Expression of the DNA Base Excision Repair Enzyme Uracil-DNA Glycosylase. Cancer Res., 66 8829-8837.
40. Lohr,K., Moritz,C., Contente,A. and Dobbclstein,M. (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem. 278, 32507-32516.
41. Shats,I., Milyavsky,M., Tang,X., Stambolsky,P., Erez,N., Brosh,R., Kogan,I., Braunstein,I., Tzukerman,M., Ginsberg,D. et al. (2004) p53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem., 279, 50976-50985.
42. Wang,L., Wei,D., Huang,S., Peng,Z., Le,X., Wu,T.T., Yao,J., Ajani,J. and Xie,K. (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin. Cancer Res., 9, 6371-6380.
43. Yao,J.C., Wang,L., Wei,D., Gong,W., Hassan,M., Wu,T.T., Mansfield,P., Ajani,J. and Xie,K. (2004) Association between expression of transcription factor Spl and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin. Cancer Res., 10, 4109-4117.
44. Banerjee,D., Gorlick,R., Liefshitz,A., Danenberg,K., Danenberg,P.C., Danenberg,P.V., Klimstra,D., Jhanwar,S., Cordon-Cardo,C., Fong,Y. et al. (2000) Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res., 60, 2365-2367.
45. Obama,K., Kanai,M., Kawai,Y., Fukushima,M. and Takabayashi,A. (2002) Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells. Int. J. Oncol., 21, 309-314.
46. Banerjee,D., Schnieders,B., Fu,J.Z., Adhikari,D., Zhao,S.C. and Bertino,J.R. (1998) Role of E2F-1 in chemosensitivity. Cancer Res. 58, 4292-4296.
47. Polager,S., Kalma,Y., Berkovich,E. and Ginsberg,D. (2002) E2Fs up-regulate expression of genes involved in DNA replication. DNA repair and mitosis. Oncogene, 21, 437-446.
48. Xu,H., Shan,J., Jurukovski,V., Yuan,L., Li,J. and Tian,K. (2007) TSP50 encodes a testis-specific protease and is negatively regulated by p53. Cancer Res., 67, 1239-1245.
49. Lankat-Buttgereit,B., Lenschen,B., Schmidt,H. and Goke,R. (2008) The action of Pdcd4 may be cell type specific: Evidence that reduction of dUTPasc levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis, 13, 157-164.
50. Longley,D.B., Ferguson,P.R., Boyer,J., Latif,T., Lynch,M., Maxwell,P., Harkin,D.P. and Johnston,P.G. (2001) Characterization of a thymidylate synthase (TS)-inducible cell line: A model system for studying sensitivity to TS- and non-TS-targeted chemotherapies. Clin. Cancer Res., 7, 3533-3539.
51. Raymond,E., Faivre,S., Waynarowski,J.M. and Chaney,S.G. (1998) Oxaliplatin: Mechanism of action and antineoplastic activity. Semin. Oncol., 25, 4-12.
52. Boyer,J., McLean,E.G., Aroori,S., Wilson,P., McCulla,A., Carey,P.D., Longley,D.B. and Johnston,P.G. (2004) Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin. Cancer Res., 10, 2158-2167.
53. Ju,J., Schmitz,J.C., Song,B., Kudo,K. and Chu,E. (2007) Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells. Clin. Cancer Res., 13, 4245-4251.
54. Kastan,M.B., Onyekwere,O., Sidransky,D., Vogelstein,B. and Craig,R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
55. Sakaguchi,K., Herrera,J.E., Saito,S., Miki,T., Bustin,M. Vassilev,A., Anderson,C.W. and Appella,E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12, 2831-2841.
56. Pietrzak,M. and Puzianowska-Kuznicka,M. (2008) p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: The role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter. Biol. Chem., 389, 383-393.
57. Dhar,S.K., Xu,Y., Chen,Y. and St Clair,D.K. (2006) Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Brol. Chem., 281, 21698-21709.
58. Zaky,A., Busso,C. Izumi,T., Chattopadhyay,R., Bassiouny,A., Mitra,S. and Bhakat,K.K. (2008) Regulation of the human AP-endonuclease (APE1,Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res., 5, 1555-1566.
59. Torgeman,A., Mor-Vaknin,N., Zelin,E., Ben-Aroya,Z., Lochelt,M., Flugel,R.M. and Aboud,M. (2001) Spl-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoyl- phorbol-13-acetate that is antagonized by protein kinase C. Virology 281, 10-20.
60. Murphy,M., Ahn,J., Walker,K.K., Hoffman,W.H., Evans,R.M., Levine,A.J. and George,D.L. (1999) Transcriptional repression by wild-type p53 utilizes historic dwacetylases, mediated by interaction with mSin3a. Genes Dev., 13, 2490-2501.
61. Twelves,C. (2002) Can capecitabine replace 5-FU leucovorin in combination with oxaliplatin for the treatment of advanced colorectal cancer? Oncology, 16, 23-26.
62. Yeh,K.H., Cheng,A.L., Wan,J.P., Lin,C.S. and Liu,C.C. (2004) Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells. Anticancer Drugs, 15 371-376.
63. Boisdron-Celle,M., Craipeau,C., Brienza,S. Delva,R., Guerin-Meyer,V., Cvitkovic.E. and Gamelin.E. (2002) Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences. Cancer Chemother. Pharmacol., 49, 235-243.